Citius Pharmaceuticals Inc (NQ: CTXR )
0.6800
+0.0850
(+14.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Headline News about Citius Pharmaceuticals Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/08/08/CTXR.png?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/466510279/8SgX5cKG.png)
![](https://public.newsdirect.com/409919572/m7g3n0Bu.png)
![](https://public.newsdirect.com/252698575/AuR9rDe9.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/21/CTXR.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/09/tea-on-a-tray.jpg)
![](https://investorplace.com/wp-content/uploads/2023/08/vfs1600-2.png)
![](https://investorplace.com/wp-content/uploads/2022/04/medical-device-stocks-hospital-stocks-healthcare-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://public.newsdirect.com/399624844/G3MtGOQh.png)
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
April 18, 2024
Via News Direct
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/ctxr.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/image45.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/csx_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/ctxr.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/04/screenshot_2023-05-04_at_5.12.04_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/aarons_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_7460.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/28/freightcar_america_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.